Alpha & Omega Semiconductor vs Magnachip Semiconductor
AOSL and MX side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AOSL and MX compare
Alpha & Omega Semiconductor is the larger company, worth 9.1 times as much as Magnachip Semiconductor ($777M against $85.8M).
Alpha & Omega Semiconductor grew revenue faster over the last twelve months (−2.5% versus −10.8% for Magnachip Semiconductor).
Alpha & Omega Semiconductor keeps more of each dollar of sales as profit, with a net margin of −6.2% compared with −17.3% at Magnachip Semiconductor.
Magnachip Semiconductor scores higher on the StockData Score (6 against 5 for Alpha & Omega Semiconductor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AOSL | MX |
|---|---|---|
| Size and price | ||
| Market cap | $777M | $85.8M |
| Share price | $25.68 | $2.35 |
| Change, 1 year | 39.1% | 0.86% |
| Change, 5 years | −40.4% | −87.2% |
| Beta (5Y) | 2.74 | 3.29 |
| Employees | 2,519 | 711 |
| StockData Score | ||
| Total score | 5 | 6 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 4 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.1× | 0.5× (better) |
| P/B | 1.0× | 0.4× (better) |
| EV/EBITDA | 42.7× | – |
| FCF yield | −8.8% (better) | −63.1% |
| Fair value | $22.37 | $12.47 |
| Margin of safety | −14.8% | 81.2% (better) |
| Growth | ||
| Revenue growth (TTM) | −2.5% (better) | −10.8% |
| Revenue growth, 5Y average | 0.66% (better) | −18.8% |
| Profitability | ||
| Gross margin | 22.3% (better) | 15.9% |
| Operating margin | −6.4% (better) | −23.2% |
| Net margin | −6.2% (better) | −17.3% |
| FCF margin | −10.0% (better) | −30.5% |
| Return on equity | −5.2% (better) | −12.3% |
| Return on invested capital | −5.1% (better) | −13.4% |
| Financial health | ||
| Debt / equity | 0.00 (better) | 0.18 |
| Net debt / EBITDA | −12.60 | – |
| Interest coverage | −55.7× | – |
| Current ratio | 3.44 (better) | 2.43 |
| Altman Z-score | 4.47 (better) | 1.89 |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | 2.3% | 5.1% (better) |
| Shareholder yield | 2.3% | 5.1% (better) |
| Ownership | ||
| Held by institutions | 75.5% | 42.8% |
| Held by insiders | 19.1% | 18.2% |
| Insider net buying, 12 months | −$2.0M | $1.4M (better) |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 14.0% | 3.5% |
Go deeper
- AOSL stock overview
- AOSL income statement
- AOSL valuation and score
- MX stock overview
- MX income statement
- MX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.